Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 20/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.61 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1670713 | 0.91 | CCR1 (0.61) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL1670417 | 0.91 | CCR1 (0.66) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL1670699 | 0.89 | CCR1 (0.66) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL1672943 | 0.88 | CCR1 (0.65) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL1670697 | 0.87 | CCR1 (0.70) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL12799627 | 0.87 | CCR1 (0.61) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL1670486 | 0.87 | CCR1 (0.65) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL12799605 | 0.86 | CCR1 (0.60) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL1671005 | 0.86 | CCR1 (0.68) | CCR1KCNH2ADRB1CYP3A4 | |
| SCHEMBL28797733 | 0.85 | CCR1 (0.59) | CCR1KCNH2ADRB1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2491028-A1 | INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2012-08-29 | — | — | EP | disclosed |
| WO-2011049917-A1 | INDAZOLE AND PYRAZOLOPYRIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-04-28 | — | — | WO | disclosed |